These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23836291)

  • 21. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
    Cuckle HS; van Lith JM
    Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
    Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P; Rodríguez I; Comas C; Puerto B
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical strategies in contingent sequential screening for Down syndrome.
    Benn P; Wright D; Cuckle H
    Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum placental growth factor and α-fetoprotein testing in first trimester screening for Down syndrome.
    Donalson K; Turner S; Morrison L; Liitti P; Nilsson C; Cuckle H
    Prenat Diagn; 2013 May; 33(5):457-61. PubMed ID: 23529706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service.
    Carmichael J; Krantz D; Liu HP; Janik D; Hallahan T
    Prenat Diagn; 2015 Jul; 35(7):703-8. PubMed ID: 25846256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland.
    Peuhkurinen S; Laitinen P; Honkasalo T; Ryynanen M; Marttala J
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):769-74. PubMed ID: 23369035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities.
    Kagan KO; Sonek J; Wagner P; Hoopmann M
    Arch Gynecol Obstet; 2017 Oct; 296(4):645-651. PubMed ID: 28702698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective validation of first-trimester combined screening for trisomy 21.
    Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal serum human placental growth hormone at 11 to 13 weeks in trisomy 21 and trisomy 18 pregnancies.
    Sifakis S; Akolekar R; Syngelaki A; De Cruz J; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):212-5. PubMed ID: 20101668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.